The molecular basis of late-onset sporadic Alzheimer’s disease (SAD), the most common form of the disorder, is still poorly understood. We hypothesize that each individual harbors genetic factors that either predispose to or protect from disease. Dr. Jessica Young will discuss her research using human pluripotent stem cells and genome-editing technology to analyze SAD phenotypes in the laboratory where her research is uncovering pathways that can be targeted with novel therapies. Join us Tuesday April 5 at 6pm at the La Jolla Riford Library to learn more!
Pingback: DIYbio events for the week of April 4 | DIYbio